Fiche du document
2008
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00428-008-0606-9
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/18392637
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/0945-6317
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_FB1A4B25BDF02
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Colorectal cancer Rectal cancer Survival skills Survival after airplane accidents, shipwrecks, etc Radiation therapy Expressive behaviorCiter ce document
H. Bouzourene et al., « The role of COX-2 in rectal cancer treated with preoperative radiotherapy. », Serveur académique Lausannois, ID : 10.1007/s00428-008-0606-9
Métriques
Partage / Export
Résumé
Radiotherapy is one of the principal modalities of rectal cancer treatment, and the ability to predict radio resistance could potentially improve survival through a targeted treatment approach. Cyclooxygenase-2 (COX-2) may protect against damage by irradiation that would justify the use of COX-2 inhibitors. The purpose of this study was to investigate the potential role of COX-2 in tumor response and outcome of patients with rectal cancer treated preoperatively with radiotherapy. Using immunohistochemistry, we examined COX-2 expression in 88 surgical specimens of rectal cancer treated preoperatively and in 26 pretherapeutic biopsies. We tested whether COX-2 expression was correlated with clinico-pathologic parameters and with survival and local recurrence. COX-2 was expressed in 50% of the pretherapeutic tumor biopsies and in 88.6% of post-irradiated surgical samples. COX-2 expression was correlated only with enhanced tumor inflammation (p = 0.03) and with tumor volume exceeding 30 cc (p = 0.05). COX-2 was not significantly correlated with patient survival, but none of the patients with COX-2 negative tumors did recur locally, whereas 80% of patients with local recurrences have COX-2 positive tumors. We conclude that COX-2 expression is overexpressed in the majority of rectal cancers treated with radiotherapy and likely plays a role in local relapse.